Organizations Filed Purposes:
OUR MISSION IS TO ACCELERATE THE DISCOVERY AND DEVELOPMENT OF CURES FOR PATIENTS WITH RARE AND DEADLY DISEASES.
TO PROMOTE AND ADVANCE SCIENTIFIC RESEARCH FOR PLATFORM CLINICAL TRIALS FOR RARE DISEASES.
1) INITIATED THE FIRST INTERNATIONAL ADAPTIVE PLATFORM TRIAL FOR BRAIN CANCER. TRIAL WAS OPENED FOR ENROLLMENT IN JUNE 2019. AS OF 12/31/19, THE TRIAL WAS OPEN AT 11 SITES AND OVER 82 PATIENTS WERE SCREENED. EFFORTS WERE ALSO UNDERWAY TO EXPAND THE TRIAL TO CHINA, EUROPE AND CANADA; 2) INITIATED DISCUSSIONS AND PLANNING FOR A TRIAL TO SUPPORT PATIENTS WITH OVARIAN CANCER; 3) ESTABLISHED GUIDANCE, INITIAL DESIGN AND OPERATIOAL DISCUSSIONS FOR A TRIAL TO SUPPORT PATIENTS WITH MDS (MYELODYSPLASTIC SYNDROME).
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Meredith Buxton | COO | 40 | $307,500 |
| Anthony Gringeri | CEO | 40 | $204,167 |
| Gary Gordon | PRESIDENT | 4 | $65,000 |
| Sujuan Ba Phd | SECRETARY | 1 | $0 |
| Webster Cavenee Md | DIRECTOR | 1 | $0 |
| Alfred Wk Yung Md | DIRECTOR | 1 | $0 |
| Brian Alexander Md | DIRECTOR | 1 | $0 |
| Timothy Cloughesy Md | DIRECTOR/OFFICER | 4 | $0 |
| John Firshkopf | DIRECTOR | 1 | $0 |
| Faramarz Yousefzadeh | DIRECTOR | 4 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202043189349306889_public.xml